Corticotropinoma-specific studies on histone deacetylases have demonstrated that a loss of HDAC2 might play a role in inducing glucocorticoid resistance43, and treatment with histone deacetylase inhibitors reduced survival and ACTH secretion in corticotroph tumor cells44. Here, POMC is linked to neoplasm.